globenewswire

Gevo Exchanges Convertible Senior Secured Notes Maturity Date for New Notes is December 31, 2020/April 1, 2021 Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 04:00
ENGLEWOOD, Colo., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
eWellness Launches Direct To Consumer PHZIO PT Treatments that include a Digital Advertising Program By February 2020 Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 04:00
Ft. Lauderdale, Florida, CA, Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
MDLIVE Launches Virtual Primary Care Platform to Improve Patient Access Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 04:00
Sunrise, Fla., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
New State of the Science Medical Program Targets the Obesity Epidemic Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 04:00
Designed by physicians for physicians, New Direction® Advanced provides doctors with the tools to effectively treat obesity in their patients. MOUNT LAUREL, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 03:05
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
IMAC Expands Reach to Southwest Florida with Purchase of Established Practice in All Cash Transaction Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 03:00
BRENTWOOD, Tenn., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 03:00
RTX-240 Investigational New Drug Application for Cancer on File with U.S. Food and Drug Administration Rubius Manufacturing Facility Operational Nine Months Ahead of Schedule and Ready to Supply Future Clinical Trials Focus on Clinical Development to Advance Three Distinct Therapeutic Approaches Across Rare Enzyme Deficiencies and Cancer CAMBRIDGE, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020 Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 03:00
MOORESTOWN, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Inovalon Announces The Inovalon ONE® Platform Cloud-Based Healthcare Data Lake Offering Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 02:55
Industry’s Most Advanced Cloud-Based Clinical Data Aggregation and Enrichment Repository BOWIE, Md., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Cytokinetics Announces Vision 2025 and Outlines 2020 Corporate Milestones Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 02:30
Top-line Results from GALACTIC-HF Now Expected in Q4 2020; Commercial Readiness Underway REDWOOD-HCM Initiated; Second Cardiac Myosin Inhibitor Planned to Enter Clinic in 1H 2020 SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
VitalHub Continues Expansion of the B Care EHR Platform in the Province of Manitoba With a Sale to Eden Health Care Services Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 02:30
TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020 Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 02:00
– Anticancer Activity of CYC065 Monotherapy in Patients with MCL1 Amplified Solid Tumors and CYC065-venetoclax combination in AML/MDS and CLL dose escalation studies – BERKELEY HEIGHTS, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Gofire, Inc. Founder and Chairman Peter Calfee to Present at 2020 ICR Conference Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 02:00
DENVER, Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
Emergent BioSolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 01:30
Full year 2019 preliminary revenues and adjusted profitability metrics in line with prior guidanceFull year 2020 forecast reflects continued growth of core business as well as investments in key development programs and operational capabilities GAITHERSBURG, Md., Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer Print E-mail
By GLOBE NEWSWIRE   
Monday, 13 January 2020 00:00
VANCOUVER, Washington, Jan. 13, 2020 (GLOBE NEWSWIRE)
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 330

Newsletter